Case Report
Alemtuzumab Plus Cyclosporine Treatment of the Autoimmune Hemolytic Anemia in an Adult Bowel Transplant
Table 1
Immunosuppressive therapies and response.
| ā | Response to therapy | ā | Transfusion need | Indirect bilirubin |
DAT |
| From November 20, 2012, to November 26, 2012 | No | No | No | HD PDN + HD Ig |
| From November 28, 2012, to January 15, 2013 | Yes | Yes | Yes | Rituximab (4) + PA (2) + sirolimus |
| From January 16, 2013, to March 06, 2013 | No | No | Yes | Rituximab (2) + HD Ig + CsA |
| From March 07, 2013, to April 10, 2014 | Yes | Yes | Yes | Alemtuzumab (3) + HD PDN + CsA |
|
|
HD PDN = high dose prednisolone; HD Ig = high dose immunoglobulin; PA = plasmapheresis; CsA = cyclosporine A; DAT = Direct Coombs Test.
|